Editorial: recognising the efficacy of licensed drug therapies for irritable bowel syndrome on bloating-a step in the right direction for targeted treatment? Authors' reply.
Saved in:
| Title: | Editorial: recognising the efficacy of licensed drug therapies for irritable bowel syndrome on bloating-a step in the right direction for targeted treatment? Authors' reply. |
|---|---|
| Authors: | Nelson AD; Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA., Black CJ; Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK.; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK., Houghton LA; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK., Lugo-Fagundo NS; Internal Medicine, Mayo Clinic, Jacksonville, FL, USA., Lacy BE; Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA., Ford AC; Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK.; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK. |
| Source: | Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 198-199. |
| Publication Type: | Editorial; Comment |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1365-2036 |
|---|---|
| DOI: | 10.1111/apt.16443 |
